These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients. Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020 [TBL] [Abstract][Full Text] [Related]
5. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer. Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419 [TBL] [Abstract][Full Text] [Related]
6. Repeatability of Crandall JP; Fraum TJ; Lee M; Jiang L; Grigsby P; Wahl RL J Nucl Med; 2021 May; 62(5):707-715. PubMed ID: 33008931 [TBL] [Abstract][Full Text] [Related]
7. Variability and Repeatability of Quantitative Uptake Metrics in Zhuang M; García DV; Kramer GM; Frings V; Smit EF; Dierckx R; Hoekstra OS; Boellaard R J Nucl Med; 2019 May; 60(5):600-607. PubMed ID: 30389824 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659 [TBL] [Abstract][Full Text] [Related]
9. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions. Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383 [TBL] [Abstract][Full Text] [Related]
10. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [TBL] [Abstract][Full Text] [Related]
11. Test-Retest Reproducibility of Kurland BF; Peterson LM; Shields AT; Lee JH; Byrd DW; Novakova-Jiresova A; Muzi M; Specht JM; Mankoff DA; Linden HM; Kinahan PE J Nucl Med; 2019 May; 60(5):608-614. PubMed ID: 30361381 [TBL] [Abstract][Full Text] [Related]
12. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET. Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481 [TBL] [Abstract][Full Text] [Related]
13. PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features. Esfahani SA; Torrado-Carvajal A; Amorim BJ; Groshar D; Domachevsky L; Bernstine H; Stein D; Gervais D; Catalano OA Mol Imaging Biol; 2022 Feb; 24(1):60-69. PubMed ID: 34622425 [TBL] [Abstract][Full Text] [Related]
14. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients. Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715 [TBL] [Abstract][Full Text] [Related]
15. Quantitative imaging of uterine cancers with diffusion-weighted MRI and 18-fluorodeoxyglucose PET/CT. Sertic M; Kilcoyne A; Catalano OA; Lee SI Abdom Radiol (NY); 2022 Sep; 47(9):3174-3188. PubMed ID: 34302185 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic efficiency of whole-body Steiner A; Narva S; Rinta-Kiikka I; Hietanen S; Hynninen J; Virtanen J Cancer Imaging; 2021 Jan; 21(1):16. PubMed ID: 33482909 [TBL] [Abstract][Full Text] [Related]
17. [(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results. Beiderwellen K; Grueneisen J; Ruhlmann V; Buderath P; Aktas B; Heusch P; Kraff O; Forsting M; Lauenstein TC; Umutlu L Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):56-65. PubMed ID: 25223420 [TBL] [Abstract][Full Text] [Related]
18. Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer. Goense L; Heethuis SE; van Rossum PSN; Voncken FEM; Lagendijk JJW; Lam MGEH; Terhaard CH; van Hillegersberg R; Ruurda JP; Mook S; van Lier ALHMW; Lin SH; Meijer GJ Nucl Med Commun; 2018 Jan; 39(1):60-67. PubMed ID: 29023336 [TBL] [Abstract][Full Text] [Related]
19. Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix. Olsen JR; Esthappan J; DeWees T; Narra VR; Dehdashti F; Siegel BA; Schwarz JK; Grigsby PW J Magn Reson Imaging; 2013 Feb; 37(2):431-4. PubMed ID: 23023940 [TBL] [Abstract][Full Text] [Related]
20. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]